While all UN sanctions are âtargetedâ in the sense that they are directed at a specific country or group, sanctions on individuals seeks to prevent harming the general population. This new tool presents new challenges, however, as names of individuals may be unfairly or hastily placed on Council lists.
MONDAY, March 19 (HealthDay News) -- A new type of medication for type 2 diabetes helps to lower blood sugar levels when used in concert with insulin and other diabetes drugs, new research suggests.
FDA Approves New Long-Acting Insulin. On February 25, 2015, the U.S. Food and Drug Administration (FDA) approved the once-daily, long-acting insulin Toujeo (generic name insulin glargine 300 U/ml) for controlling blood glucose in adults with Type 1 and Type 2 diabetes.